Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 79

1.

Effects of zoledronate on irradiated bone in vivo: analysis of the collagen types I, V and their cross-links lysylpyridinoline, hydroxylysylpyridinoline and hydroxyproline.

Açil Y, Gierloff M, Behrens C, Möller B, Gassling V, Niehoff P, Wiltfang J, Simon M.

Calcif Tissue Int. 2013 Mar;92(3):251-60. doi: 10.1007/s00223-012-9676-4. Epub 2012 Nov 21.

PMID:
23179106
2.

Effects of zoledronate on the radiation-induced collagen breakdown: a prospective randomized clinical trial.

Gierloff M, Reutemann M, Gülses A, Niehoff P, Wiltfang J, Açil Y.

Clin Transl Oncol. 2015 Jun;17(6):454-61. doi: 10.1007/s12094-014-1257-8. Epub 2014 Nov 26.

PMID:
25425023
3.

The impact of bisphosphonates on the osteoblast proliferation and Collagen gene expression in vitro.

Koch FP, Yekta SS, Merkel C, Ziebart T, Smeets R.

Head Face Med. 2010 Jul 9;6:12. doi: 10.1186/1746-160X-6-12.

4.

Bone metabolic effects of single-dose zoledronate in healthy dogs.

de Lorimier LP, Fan TM.

J Vet Intern Med. 2005 Nov-Dec;19(6):924-7.

5.
6.

Effects of intravenous zoledronate on bone turnover and BMD persist for at least 24 months.

Bolland MJ, Grey AB, Horne AM, Briggs SE, Thomas MG, Ellis-Pegler RB, Callon KE, Gamble GD, Reid IR.

J Bone Miner Res. 2008 Aug;23(8):1304-8. doi: 10.1359/jbmr.080312.

7.

Inhibition of osteoblast function in vitro by aminobisphosphonates.

Orriss IR, Key ML, Colston KW, Arnett TR.

J Cell Biochem. 2009 Jan 1;106(1):109-18. doi: 10.1002/jcb.21983.

PMID:
19003973
8.

Effects of alfacalcidol on mechanical properties and collagen cross-links of the femoral diaphysis in glucocorticoid-treated rats.

Saito M, Marumo K, Ushiku C, Kato S, Sakai S, Hayakawa N, Mihara M, Shiraishi A.

Calcif Tissue Int. 2011 Apr;88(4):314-24. doi: 10.1007/s00223-011-9472-6. Epub 2011 Feb 13.

PMID:
21327766
9.

Bisphosphonates do not inhibit periosteal bone formation in estrogen deficient animals and allow enhanced bone modeling in response to mechanical loading.

Feher A, Koivunemi A, Koivunemi M, Fuchs RK, Burr DB, Phipps RJ, Reinwald S, Allen MR.

Bone. 2010 Jan;46(1):203-7. doi: 10.1016/j.bone.2009.10.023. Epub 2009 Oct 24.

PMID:
19857619
10.
11.

Surface immobilized zoledronate improves screw fixation in rat bone: a new method for the coating of metal implants.

Andersson T, Agholme F, Aspenberg P, Tengvall P.

J Mater Sci Mater Med. 2010 Nov;21(11):3029-37. doi: 10.1007/s10856-010-4154-x. Epub 2010 Sep 21.

PMID:
20857321
12.

Pharmacokinetic and therapeutic efficacy of intrapulmonary administration of zoledronate for the prevention of bone destruction in rheumatoid arthritis.

Katsumi H, Mozume T, Yanagi S, Hasei T, Watanabe T, Sakane T, Yamamoto A.

J Drug Target. 2016;24(6):530-6. doi: 10.3109/1061186X.2015.1101768. Epub 2015 Oct 27.

PMID:
26508267
13.
14.

The impact of dietary calcium intake and vitamin D status on the effects of zoledronate.

Bourke S, Bolland MJ, Grey A, Horne AM, Wattie DJ, Wong S, Gamble GD, Reid IR.

Osteoporos Int. 2013 Jan;24(1):349-54. doi: 10.1007/s00198-012-2117-4. Epub 2012 Aug 15.

PMID:
22893357
15.
16.

Skeletal remodeling following clinically relevant radiation-induced bone damage treated with zoledronic acid.

Hui SK, Fairchild GR, Kidder LS, Sharma M, Bhattacharya M, Jackson S, Le C, Yee D.

Calcif Tissue Int. 2012 Jan;90(1):40-9. doi: 10.1007/s00223-011-9547-4. Epub 2011 Nov 15.

PMID:
22083107
17.

Pharmacological effects of tiludronate in horses after long-term immobilization.

Delguste C, Amory H, Doucet M, Piccot-Crézollet C, Thibaud D, Garnero P, Detilleux J, Lepage OM.

Bone. 2007 Sep;41(3):414-21. Epub 2007 May 23.

PMID:
17604709
18.

Five years of anti-resorptive activity after a single dose of zoledronate--results from a randomized double-blind placebo-controlled trial.

Grey A, Bolland MJ, Horne A, Wattie D, House M, Gamble G, Reid IR.

Bone. 2012 Jun;50(6):1389-93. doi: 10.1016/j.bone.2012.03.016. Epub 2012 Mar 24.

PMID:
22465268
19.

Zoledronate inhibits the proliferation, adhesion and migration of vascular smooth muscle cells.

Wu L, Zhu L, Shi WH, Zhang J, Ma D, Yu B.

Eur J Pharmacol. 2009 Jan 5;602(1):124-31. doi: 10.1016/j.ejphar.2008.10.043. Epub 2008 Oct 31.

PMID:
19000670
20.

Supplemental Content

Support Center